RecruitingPhase 2NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Sponsor: Aspeya, Inc.
Lemon Grove, CA · Walnut Creek, CA · +18 more sites